Paper41599783
Emerging Breakthroughs in Nano-Ginseng Innovations and Their Therapeutic Implications in Type 2 Diabetes.
Tiwari P and 2 others. Pharmaceuticals (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Emerging Breakthroughs in Nano-Ginseng Innovations and Their Therapeutic Implications in Type 2 Diabetes. Papers, record 41599783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41599783
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Emerging Breakthroughs in Nano-Ginseng Innovations and Their Therapeutic Implications in Type 2 Diabetes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PNURSP2025R155, RGP RGP2/298/46 | Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, Deanship of Scientific Research and Graduate Studies at King Khalid University | PubMed |
Source PubMed
References157
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34386322 | Ginsenosides in Panax genus and their biosynthesis. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/34386322 | PubMed |
| 2 | 21811928 | The antidiabetic effect of ginsenoside Rb2 via activation of AMPK. | Arch Pharm Res | 2011 | https://conductscience.org/library/papers/21811928 | PubMed |
| 3 | 35580686 | IgG functionalized polymeric nanoparticles for oral insulin administration. | Int J Pharm | 2022 | https://conductscience.org/library/papers/35580686 | PubMed |
| 4 | 28687934 | Co-administration of a konjac-based fibre blend and American ginseng (Panax quinquefolius L.) on glycaemic control and serum lipids in type 2 diabetes: a randomized controlled, cross-over clinical trial. | Eur J Nutr | 2018 | https://conductscience.org/library/papers/28687934 | PubMed |
| 5 | 28697660 | Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer's disease? | J Drug Target | 2018 | https://conductscience.org/library/papers/28697660 | PubMed |
| 6 | 26273667 | Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update. | J Diabetes Res | 2015 | https://conductscience.org/library/papers/26273667 | PubMed |
| 7 | 26058590 | Structure Activity Relationship Studies of Gymnemic Acid Analogues for Antidiabetic Activity Targeting PPARγ. | Curr Comput Aided Drug Des | 2015 | https://conductscience.org/library/papers/26058590 | PubMed |
| 8 | 36404771 | Optimization of process parameters for fabrication of electrospun nanofibers containing neomycin sulfate and Malva sylvestris extract for a better diabetic wound healing. | Drug Deliv | 2022 | https://conductscience.org/library/papers/36404771 | PubMed |
| 9 | 23945406 | Effect of Korean red ginseng on insulin sensitivity in non-diabetic healthy overweight and obese adults. | Asia Pac J Clin Nutr | 2013 | https://conductscience.org/library/papers/23945406 | PubMed |
| 10 | 11592833 | Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. | Mol Ther | 2001 | https://conductscience.org/library/papers/11592833 | PubMed |
| 11 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 12 | 27746687 | Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue. | J Ginseng Res | 2016 | https://conductscience.org/library/papers/27746687 | PubMed |
| 13 | 39926039 | Ginsenosides 20R-Rg3 and Rg5 enriched black ginseng inhibits colorectal cancer tumor growth by activating the Akt/Bax/caspase-3 pathway and modulating gut microbiota in mice. | Curr Res Food Sci | 2025 | https://conductscience.org/library/papers/39926039 | PubMed |
| 14 | 31975748 | Standards of Medical Care in Diabetes-2020 Abridged for Primary Care Providers. | Clin Diabetes | 2020 | https://conductscience.org/library/papers/31975748 | PubMed |
| 15 | 31862745 | 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. | Diabetes Care | 2020 | https://conductscience.org/library/papers/31862745 | PubMed |
| 16 | 32210082 | Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32210082 | PubMed |
| 17 | 26921515 | Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies. | Int J Pharm | 2016 | https://conductscience.org/library/papers/26921515 | PubMed |
| 18 | 29478187 | Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over clinical trial. | Eur J Nutr | 2019 | https://conductscience.org/library/papers/29478187 | PubMed |
| 19 | 31423670 | Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation. | Adv Mater | 2020 | https://conductscience.org/library/papers/31423670 | PubMed |
| 20 | 35038475 | Glucose sensitive konjac glucomannan/concanavalin A nanoparticles as oral insulin delivery system. | Int J Biol Macromol | 2022 | https://conductscience.org/library/papers/35038475 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41599783
GET https://conductscience.org/api/papers/v1/41599783/references?page=2